Mansukh Mandaviya urges pharma industry to work towards increasing share of generic drugs in India

NEW DELHI: Union health minister Mansukh Mandaviya on Thursday urged the pharma industry to consider domestic manufacturing of medicines which are soon going to be off patent under Atmanirbhar Bharat and also to work towards increasing the share of generic drugs in the country.

He was addressing a session on ‘Ensuring Affordable, Accessible Health for All’ at the CII Annual Meeting 2021.

The minister urged the pharma industry to consider domestic manufacturing of medicines which are soon going to be off patent and said the PLI scheme announced by the government would help the domestic industry in this endeavour.

He said initiatives such as the medical devices park, pharma park, PLI will help the industry to grow in the coming days.

He also assured the industry of all possible support to improve health infrastructure and sought cooperation and inputs to improve ease of doing business and competitiveness of this sector.

The government and industry partnership to make healthcare accessible and affordable assumes importance in a country like India as sickness increases the cost for the poor and impedes progress, the minister who holds the charge of the Ministry of Chemicals and Fertilizers said.

“If any country has to prosper, among many parameters, one is that the citizens of the country have to be healthy and for that health facilities have to be affordable and accessible,” he said.

The minister lauded the private sector for working in tandem with the government to meet the shortage of healthcare facilities, oxygen, injections, medicines etc during the pandemic.

Many companies repurposed their processes for production of critical care health requirements on a large scale, including masks, PPEs, and ventilators, he said.

Speaking about initiatives for providing affordable healthcare, the minister mentioned the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) and noted how the number of Janaushadhhi kendras had gone up to over 8,000 in 2016 from 103, while the number of medicines available at these stores had also increased.

It is a direct end to end chain with no middlemen, he said, adding the private sector is also participating in this initiative by submitting tenders.

Alluding to the Ayushman Bharat insurance scheme, he said over 2 crore families have benefitted from it and private hospitals are also participating in the mission.

The minister said in a democratic system, when people and government work together only then the country can prosper. The best example of how the corporate sector and industries can work together and give output was seen during the COVID-19 crisis management, he added.

About the first lockdown which was imposed nationwide following an announcement by Prime Minister Narendra Modi, he said it was imposed as India did not have PPE kits, ventilators, also drugs were not available in enough qualities, and people were not trained and did not have the experience.

In a country like India, despite the huge diversity and different strata of people, migration and other situations, the lockdown was imposed for one and half months and everybody worked collectively to make it successful, Mandaviya said.

The government did its part, industries did whatever they could for their employees, NGOs did whatever they could do, and people and families took care of each other in the community and neighbourhood. Whereas even in several developed countries, people had agitated against the lockdown, Mandaviya pointed out.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore